Pharmaceutical-business-review - pharmaceutical-business-review.com - PBR - News
General Information:
Latest News:
SBI Pharma plans new diabetes, cancer medication production facility in Bahrain 27 Aug 2013 | 05:38 pm
Japan-based SBI Pharma is likely to set up a new diabetes and cancer medication production facility in Bahrain.
Earths Options launches Glucosamine Chondroitin supplement for joint pain relief 27 Aug 2013 | 04:35 pm
Newly established company Earths Options has rolled out its latest health supplement product, dubbed as Glucosamine Chondroitin MSM, to cure painful joint problems.
Kirkman launches new nutritional supplement with calcium/magnesium 27 Aug 2013 | 04:20 pm
Kirkman, a dietary supplement manufacturer, has rolled out its new nutritional product, known as Calcium/Magnesium – Hypoallergenic, which gives calcium blended with magnesium for comprehensive care, ...
FDA approves Galderma's Mirvaso for treatment of facial redness 27 Aug 2013 | 04:19 pm
The US Food and Drug Administration (FDA) has approved Mirvaso (brimonidine) topical gel, produced by Galderma Laboratories, for the topical treatment of the facial erythema (redness) of Rosacea in ad...
Novan wins $7.8m BARDA contract to develop medical countermeasure for thermal burns 27 Aug 2013 | 04:14 pm
The US Department of Health and Human Services has awarded a $7.8m the Biomedical Advanced Research and Development Authority (BARDA) contract to Novan Therapeutics to develop a medical countermeasure...
Curemark collaborates with VTT/MSI Molecular Sciences Institute 27 Aug 2013 | 04:12 pm
Drug research and development company Curemark has collaborated with the VTT/MSI Molecular Sciences Institute (MSI) in Berkeley, California, for research.
Bharat Biotech introduces new typhoid conjugate vaccine 27 Aug 2013 | 04:10 pm
Biotechnology company Bharat Biotech has introduced world's first clinically proven typhoid conjugate vaccine, Typbar-TCV, to protect infants aged six months and more and adults from typhoid fever cau...
Alcobra begins enrollment in comparative study of MG01CI 27 Aug 2013 | 04:05 pm
Biopharmaceutical company Alcobra has enrolled first patient in comparative study of MG01CI to compare varied doses in improving executive function benefits in patients with predominantly inattentive ...
Laureate, Dyax partner for hereditary angioedema drug candidate production 27 Aug 2013 | 11:05 am
Laureate Biopharma has collaborated with Dyax for process development and cGMP production of new hereditary angioedema (HAE) drug candidate, DX-2930.
Sanofi Pasteur begins Phase III study of Clostridium difficile vaccine in Canada 27 Aug 2013 | 11:00 am
Sanofi Pasteur, a vaccine division, has commenced Phase III clinical program, called Cdiffense, of investigational vaccine in Canada to prevent Clostridium difficile.
